897627-79-1Relevant articles and documents
Cd(NO3)2.4H2O catalyzed one-pot synthesis of 1,4-dihydropyridine and polyhydroquinoline derivatives through the Hantzsch multicomponent condensation
Tafer, Radia,Boulcina, Raouf,Carboni, Bertrand,Debache, Abdelmadjid
, p. 1555 - 1560 (2012)
The synthesis of various 1,4-dihydropyridine and polyhydroquinoline derivatives was achieved in good to excellent yields using cadmium (II) nitrate as catalyst to promote the classical andmodified Hantzsch conditions in good yields under mild conditions.
An efficient one-step synthesis of 1,4-dihydropyridines via a triphenylphosphine-catalyzed three-component Hantzsch reaction under mild conditions
Debache, Abdelmadjid,Ghalem, Wassima,Boulcina, Raouf,Belfaitah, Ali,Rhouati, Salah,Carboni, Bertrand
experimental part, p. 5248 - 5250 (2009/12/06)
An efficient one-step synthesis of 1,4-dihydropyridines in good to excellent yields via the triphenylphosphine-catalyzed Hantzsch three-component reaction of an aromatic aldehyde, ethyl acetoacetate and ammonium acetate is described.
COMPOUNDS AND COMBINATIONS THEREOF FOR INHIBITING BETA-AMYLOID PRODUCTION AND METHODS OF USE THEREOF
-
Page/Page column 139, (2010/11/29)
Provided are compounds which can be used in combination for treating diseases associated with a condition associated with cerebral accumulation of Alzheimer’s amyloid, such as Alzheimer’s disease. Also provided are methods of treating or reducing the risk of developing β-amyloid production, β-amyloid deposition, β-amyloid neurotoxicity (including abnormal hyperphosphorylation of tau) and microgliosis associated with cerebral accumulation of Alzheimer’s amyloid by administering therapeutically effective amounts of compounds which in combination can decrease β-amyloid production and capacitative calcium entry in cells. Further provided are methods for diagnosing diseases associated with cerebral accumulation of Alzheimer’s amyloid in animals or humans by administering diagnostically effective amounts of the compounds.